Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2607-2611

  Renner, P ^a   Eggenhofer, E ^a   Rosenauer, A ^a   Popp, F C ^a   Steinmann, J F ^a   Slowik, P ^a   Geissler, E K ^a   Piso, P ^a   Schlitt, H J ^a   Dahlke, M H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COCULTURE; CONTROLLED STUDY; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL CULTURE TECHNIQUES; FLOW CYTOMETRY; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MODELS, ANIMAL; RATS; RATS, INBRED ACI; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 68949199491     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.119     Document Type: Article

References (28)

1. Crop M., Baan C., Weimar W., et al. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int 22 (2009) 365
2. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8 (2008) 726
3. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42
4. Di N.M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838
5. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003) 3722
6. Le Blanc K., and Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262 (2007) 509
7. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815
8. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5 (2003) 485
9. Potian J.A., Aviv H., Ponzio N.M., et al. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171 (2003) 3426
10. Krampera M., Cosmi L., Angeli R., et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24 (2006) 386
11. Xu G., Zhang L., Ren G., et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 17 (2007) 240
12. Djouad F., Charbonnier L.M., Bouffi C., et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an IL-6-dependent mechanism. Stem Cells 25 (2007) 2025
13. Meisel R., Zibert A., Gobel U., et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619
14. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389
15. Casiraghi F., Azzollini N., Cassis P., et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181 (2008) 3933
16. Popp F.C., Eggenhofer E., Renner P., et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 20 (2008) 55
17. Zhou H.P., Yi D.H., Yu S.Q., et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 38 (2006) 3046
18. Inoue S., Popp F.C., Koehl G.E., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81 (2006) 1589
19. Chabannes D., Hill M., Merieau E., et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110 (2007) 3691
20. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143
21. Hoogduijn M.J., Crop M.J., Peeters A.M., et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16 (2007) 597
22. Ren C., Kumar S., Chanda D., et al. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 26 (2008) 2332
23. Stagg J., Pommey S., Eliopoulos N., et al. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 107 (2006) 2570
24. Prigozhina T.B., Khitrin S., Elkin G., et al. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Exp Hematol 36 (2008) 1370
25. Le Blanc K., Tammik L., Sundberg B., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (2003) 11
26. Chan J.L., Tang K.C., Patel A.P., et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107 (2006) 4817
27. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499
28. Ren G., Zhang L., Zhao X., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2 (2008) 141